Peptidyl-lysine oxidation

pathway activity — cross-omics
GO:0018057Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-lysine oxidation pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are COL6A3, LOX, and COL1A2, each associated with the pathway in up to 10 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-lysine oxidation activity versus COL6A3 in GBM (Pearson r = 0.49).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMCOL6A3 →+1.435+0.140.002<.001310
GBMLOX →+1.277+0.138<.001<.00139
BRCACOL1A2 →+1.452+0.284<.001.00339
LSCCFBN1 →+0.933+0.132<.001<.00139
OVCOL1A1 →+1.540+0.117.008.00839
LSCCCOL5A1 →+1.690+0.228<.001<.00139
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018057 vs COL6A3 — GBM

Per-sample scatter of Peptidyl-lysine oxidation activity vs COL6A3 in GBM.

Explore this scatter interactively →

Exploration